Remove IPO Remove Medical Remove Shares
article thumbnail

Virtualware Acquires Sweden's Simumatik to Strengthen Position in the Real-Time 3D Enterprise Software Industry

Global Newswire by Notified: M&A

As per the terms of the transaction, Virtualware will make a cash payment of around 450,000 euros in exchange for the Swedish company, plus a share payment of 110,000 shares of Virtualware at a market price of 8.40 The company's current market capitalization exceeds 38 million euros, and its share price currently stands at 8.40

Shares 56
article thumbnail

Elevating Expertise: Senior Advisor Spotlight, Jonathan Wilfong

Focus Investment Banking

These required M&A transactions to bring 75 medical practices together in the two firms. Their combined IPO capitalizations exceeded $125 million. He also co-founded Ouch.com, an online medical supply superstore and collaborated with major medical associations including the Orthopaedic Foundation of America.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Shareholders vs. Stakeholders - Understanding Corporate Responsibilities

Peak Frameworks

A shareholder is an individual or entity that owns shares or stock in a corporation. Types of Shareholders: Common Shareholders : These individuals hold common shares, entitling them to voting rights and dividends. By virtue of their ownership, they possess a direct financial interest in the company's success.

article thumbnail

Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024

Cooley M&A

Strained access to public markets and funding The IPO market remained relatively inactive in 2023, leading many life sciences companies looking to raise funds to turn to other exit strategies. Additional major acquisitions of 2023 included Pfizer’s acquisition of Seagen for $43 billion and Merck’s acquisition of Prometheus for $10.8

M&A 52
article thumbnail

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley M&A

In November, Johnson & Johnson announced that it will split itself into two publicly traded companies , separating its pharmaceutical and medical devices businesses from its consumer products business. DeSPAC transactions also hit an all? As we noted in our 2020 year?end time highs in 2021.

M&A 40
article thumbnail

Cooley’s 2022 Tech M&A Year in Review

Cooley M&A

Faced with depressed venture funding activity (which for digital health declined nearly 50% from 2021 ), an uncertain IPO market and pressure to provide liquidity to investors, M&A offered digital health startups a solution to deliver liquidity, streamline costs and bridge funding gaps as they continue to develop their products.

M&A 52
article thumbnail

Biotech Hedge Funds: A Match Made in Heaven

Mergers and Inquisitions

their Enterprise Values are not worth much for a long time): Hedge funds focusing on public biotech companies step into this process after the IPO part, which means they can bet on extreme value inflections based on binary outcomes. If you have an advanced medical or academic background (e.g., or Ph.D.),

Funds 64